The Gemini Brief - Investment Deep Dives podcast

AbbVie: a pharma giant navigating its defining transition (ABBV)

0:00
52:03
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder
Slide Deck AbbVie has executed what may be the most successful franchise replacement in pharmaceutical history. The company’s combined Skyrizi and Rinvoq revenues reached $25.9 billion in 2025 — surpassing Humira’s all-time peak of $21.2 billion — while Humira itself declined to $4.5 billion from that peak. Total revenue hit a record $61.2 billion in […]

Fler avsnitt från "The Gemini Brief - Investment Deep Dives"